| Literature DB >> 31741438 |
Michael J Wilkinson1, Adena Zadourian1, Pam R Taub2.
Abstract
Type 2 diabetes mellitus and congestive heart failure are highly prevalent diseases with significant morbidity and mortality. These 2 diseases often occur concurrently because of shared risk factors such as coronary artery disease, and also because type 2 diabetes mellitus has direct cardiotoxic effects. Type 2 diabetes mellitus likely has a causative role in the development and prognosis of patients with heart failure. Optimal prevention and treatment of type 2 diabetes mellitus and heart failure likely involves identifying and treating their shared pathophysiologic features. Novel drug therapies, such as sodium-glucose co-transporter 2 inhibitors, offer an exciting potential to better understand the relationship between type 2 diabetes mellitus and heart failure, and may prove to have beneficial effects on cardiovascular outcomes in patients affected by these diseases.Entities:
Year: 2019 PMID: 31741438 DOI: 10.1016/j.amjcard.2019.10.024
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778